Application of Molecular and Genomic Biomarker Testing in Hematopathology is organized by Florida Society of Pathologists (FSP).
Release Date: March 13, 2025
Expiration Date: March 13, 2026
Description:
This webinar will cover the latest application of molecular and genomic biomarker testing in hematologic malignancies. Learners will gain a deeper understanding of how molecular and genomic testing is used to shape personalized treatment plans for patients with hematologic malignancies. The faculty will discuss ways to interpret and report test results so that hematologists and oncologists are supported as they develop treatment plans for patients.
Learning Objectives:
At the conclusion of this activity, learners should be better able to:
Accreditation and Credit Designation
In support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and Florida Society of Pathologists (FSP). American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians
American Academy of CME, Inc., designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other members of the care team will receive a certificate of participation.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved